You are here

Argos

Argos finds silver lining for I/O candidate

BioPharma Dive

Tue, 11/14/17 - 07:55 pm

immuno-oncology

rocapuldencel-T

Argos’ PhIII for its personalized cancer vaccine implodes during an interim analysis

Endpoints

Wed, 02/22/17 - 09:49 am

personalized medicine

rocapuldencel-T

renal cell carcinoma

Argos swings for a $60M IPO in the shadow of Dendreon's struggles

Fierce Biotech

Tue, 12/31/13 - 11:42 am

personalized medicine

renal cell carcinoma

IPO Preview: Argos Therapeutics

Seeking Alpha

Wed, 02/29/12 - 10:05 am

ONYX Pharmaceuticals

Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab

BNET Pharma

Mon, 05/24/10 - 08:03 am

personalized medicine